phenylalanine and bortezomib

phenylalanine has been researched along with bortezomib in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Berkers, CR; Groll, M; Ovaa, H; Ploegh, HL1
Hattori, Y; Ishimura, M; Kirihata, M; Ohta, Y; Ono, K; Takenaka, H; Tanaka, H; Watanabe, T1
de Bruin, G; Florea, BI; Hoogendoorn, S; Mazurek, J; Mock, ED; Overkleeft, HS; van den Nieuwendijk, AM; van der Marel, GA1
Emeh, P; Eskelinen, A; Gebraad, A; Heckman, CA; Kuismanen, K; Lehmann, F; Manninen, M; Miettinen, JJ; Miettinen, S; Nupponen, NN; Ohlsbom, R; Pakarinen, TK; Slipicevic, A1

Other Studies

4 other study(ies) available for phenylalanine and bortezomib

ArticleYear
Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome.
    Structure (London, England : 1993), 2006, Volume: 14, Issue:3

    Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Catalytic Domain; Crystallization; Leucine; Mammals; Models, Molecular; Peptides; Phenylalanine; Proteasome Endopeptidase Complex; Protein Structure, Quaternary; Pyrazinamide; Pyrazines; Structure-Activity Relationship; Substrate Specificity; Yeasts

2006
Detection of boronic acid derivatives in cells using a fluorescent sensor.
    Organic & biomolecular chemistry, 2015, Jul-07, Volume: 13, Issue:25

    Topics: Antineoplastic Agents; Boron; Boron Compounds; Boronic Acids; Bortezomib; Cell Line, Tumor; Chelating Agents; Fluorescent Dyes; Humans; Optical Imaging; Phenylalanine; Spectrometry, Fluorescence

2015
Enantioselective synthesis of adamantylalanine and carboranylalanine and their incorporation into the proteasome inhibitor bortezomib.
    Chemical communications (Cambridge, England), 2016, Mar-14, Volume: 52, Issue:21

    Topics: Adamantane; Boron Compounds; Bortezomib; Cell Line, Tumor; Humans; Phenylalanine; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Stereoisomerism; Sulfonium Compounds

2016
Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen.
    Cells, 2022, 05-07, Volume: 11, Issue:9

    Topics: Bone Marrow; Bortezomib; Doxorubicin; Humans; Melphalan; Mesenchymal Stem Cells; Multiple Myeloma; Phenylalanine

2022